
Topic
Prior Authorization
Documentation, step edits, renewal cycles, appeals, and how payer criteria shape real-world drug use.

Pricing & Access· May 31, 2026 · 13 min read
By Ran Chen#GLP-1#Prior Authorization#Medicare Part D

Pricing & Access· May 31, 2026 · 12 min read
GLP-1 restart after treatment interruption: PA documentation and dosing
By Ran Chen#GLP-1#Prior Authorization#Specialty Drugs

Specialty· May 31, 2026 · 11 min read
Limited distribution specialty pharmacy lockout and payer mandates

Pricing & Access· May 31, 2026 · 15 min read
Medicare GLP-1 Bridge PA evidence file and documentation
By Ran Chen#GLP-1#Medicare Part D#Prior Authorization

Pricing & Access· May 31, 2026 · 13 min read
Medicare GLP-1 Bridge patient ineligibility traps
By Ran Chen#Medicare Part D#GLP-1#Prior Authorization

Pricing & Access· May 31, 2026 · 11 min read
Medicare Part D transition fill vs manufacturer bridge programs

Pipeline· May 31, 2026 · 10 min read
Olezarsen Tryngolza sNDA preview for severe hypertriglyceridemia
By Ran Chen#PDUFA Date#FDA Approval#Clinical Evidence

Pricing & Access· May 31, 2026 · 9 min read
Oral GLP-1 launch access checklist: payer team readiness before approval
By Ran Chen#GLP-1#Oral GLP-1#Payer Policy

Pricing & Access· May 31, 2026 · 12 min read
Renewal denial after stable disease: documenting continued benefit

Specialty· May 31, 2026 · 13 min read